Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
NCT ID: NCT05945784
Last Updated: 2023-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
57 participants
OBSERVATIONAL
2023-07-21
2023-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research in the field of accessible design has highlighted the importance of inclusive product development across various industries, including cosmetics and personal care. However, limited attention has been given specifically to beauty products and their usability for individuals with upper extremity disabilities.
To address this gap, studies are being conducted to assess the accessibility of beauty products and identify potential barriers and solutions. These studies typically examine factors such as packaging design, ergonomics of product applicators, ease of grip, and maneuverability. By understanding the specific challenges faced by individuals with upper extremity disabilities, researchers can propose modifications and design considerations that enhance accessibility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Minimal to moderate upper extremity deficits
* Individuals aged 18 years to 55 years.
* Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments.
* Regular users of beauty products.
* Able to understand and communicate in the language of the study.
Use of Rare Beauty makeup products
Participants will be provided with a selection of beauty products items including foundation, concealer, blush, highlighter, and lipstick, specifically chosen for their potential accessibility features. They will have a specified trial period during which they can use the products as part of their regular beauty routines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of Rare Beauty makeup products
Participants will be provided with a selection of beauty products items including foundation, concealer, blush, highlighter, and lipstick, specifically chosen for their potential accessibility features. They will have a specified trial period during which they can use the products as part of their regular beauty routines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments.
* Regular users beauty products.
* Able to understand and communicate in the language of the study.
Exclusion Criteria
* Individuals without upper extremity deficits or with severe upper extremity deficits that may affect the participant's ability to engage in study activities.
* Participants who are not regular users of beauty products.
* Inability to understand and communicate in the language of the study.
* Any medical or psychological condition that may affect the participant's ability to provide informed consent or engage in the study activities safely.
* Individuals who experience facial skin or eye irritation reported by subject or observed by evaluator at baseline visit
* History of allergic reactions, and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc.
* Immunocompromised subjects
* Individuals who may experience changes in hormones, such as just those using oral contraception for less than three months before the screening visit or who have changed hormonal contraceptive methods within the three months before the Baseline visit or planning to modify hormonal contraception treatment within the duration of the study.
* Known to be pregnant, lactating or planning to become pregnant within six months. Subjects who become pregnant during the study must inform the Principal Investigator immediately.
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Casa Colina Hospital and Centers for Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily Rosario
Executive Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Rosario, PhD
Role: PRINCIPAL_INVESTIGATOR
Casa Colina Hospital and Centers for Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Casa Colina Hospital and Centers for Healthcare
Pomona, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Skelton H, Gill S, Al Zidjaly N, et al. Exploring the Accessibility of Beauty Products for Individuals with Mobility Disabilities. J Appl Cosmetol. 2020;38(3):65-72.
Smith A, Johnson R, Thompson A, et al. Enhancing Accessibility: Designing Inclusive Beauty Products for All Abilities. J Inclusive Design. 2021;1(2):89-102
Chen L, Kim D, Park J, et al. A Review on Product Accessibility Evaluation Methods for People with Disabilities. Int J Ind Ergon. 2019;71:103-117. doi:10.1016/j.ergon.2018.11.007
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB: 000000001
Identifier Type: -
Identifier Source: org_study_id